Matthew B. Klein insider trades: ClearPoint Neuro (CLPT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Matthew reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | CLPT | ↓ Sell | 16,000 | $11.59 | $185K | Direct | May 26, 2026 (5d) |
| May 14, 2026 | PTCT | ↓ Sell | 12,572 | $72.95 | $917K | Direct | May 15, 2026 (1d) |
| Feb 18, 2026 | PTCT | ↓ Sell | 7,371 | $69.36 | $511K | Direct | Feb 20, 2026 (2d) |
| Jan 8, 2026 | PTCT | ↓ Sell | 2,514 | $76.45 | $192K | Direct | Jan 12, 2026 (4d) |
| Jan 7, 2026 | PTCT | ↓ Sell | 8,165 | $77.15 | $630K | Direct | Jan 8, 2026 (1d) |
| Dec 30, 2025 | PTCT | ↓ Sell | 8,089 | $76.64 | $620K | Direct | Jan 2, 2026 (3d) |
| Dec 2, 2025 | PTCT | ↓ Sell | 3,428 | $79.07 | $271K | Direct | Dec 3, 2025 (1d) |
| Aug 5, 2025 | PTCT | ↓ Sell | 10,739 | $51.74 | $556K | Direct | Aug 5, 2025 (0d) |
| Apr 22, 2025 | PTCT | ↓ Sell | 2,804 | $48.74 | $137K | Direct | Apr 24, 2025 (2d) |
| Feb 20, 2025 | PTCT | ↓ Sell | 7,792 | $50.11 | $390K | Direct | Feb 21, 2025 (1d) |
| Jan 8, 2025 | PTCT | ↓ Sell | 4,544 | $44.90 | $204K | Direct | Jan 10, 2025 (2d) |
| Dec 31, 2024 | PTCT | ↓ Sell | 8,279 | $45.16 | $374K | Direct | Jan 3, 2025 (3d) |
| Apr 19, 2024 | PTCT | ↓ Sell | 3,361 | $24.89 | $84K | Direct | Apr 22, 2024 (3d) |
| Apr 17, 2024 | PTCT | ↓ Sell | 1,307 | $25.13 | $33K | Direct | Apr 19, 2024 (2d) |
| Jan 9, 2024 | PTCT | ↓ Sell | 7,680 | $28.91 | $222K | Direct | Jan 10, 2024 (1d) |
| Jan 5, 2024 | PTCT | ↓ Sell | 10,107 | $27.15 | $274K | Direct | Jan 9, 2024 (4d) |
| Apr 18, 2023 | PTCT | ↓ Sell | 1,211 | $52.04 | $63K | Direct | Apr 20, 2023 (2d) |
| Jan 11, 2023 | PTCT | ↓ Sell | 4,517 | $43.64 | $197K | Direct | Jan 12, 2023 (1d) |
| Jan 9, 2023 | PTCT | ↓ Sell | 731 | $41.66 | $30K | Direct | Jan 11, 2023 (2d) |
| Apr 19, 2022 | PTCT | ↓ Sell | 897 | $42.52 | $38K | Direct | Apr 21, 2022 (2d) |
| Jan 7, 2022 | PTCT | ↓ Sell | 775 | $38.52 | $30K | Direct | Jan 11, 2022 (4d) |
| Apr 20, 2021 | PTCT | ↓ Sell | 2,500 | $47.23 | $118K | Direct | Apr 21, 2021 (1d) |
| Jan 15, 2021 | PTCT | ↓ Sell | 4,300 | $69.09 | $297K | Direct | Jan 20, 2021 (5d) |
| Jan 8, 2021 | PTCT | ↓ Sell | 5,500 | $69.71 | $383K | Direct | Jan 12, 2021 (4d) |
| Jan 7, 2021 | PTCT | ↓ Sell | 3,886 | $68.98 | $268K | Direct | Jan 8, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CLPT insiders
Open-market trades in the last 12 months
About Matthew B. Klein's insider trades
Matthew B. Klein is an insider at ClearPoint Neuro (CLPT). Since Jan 7, 2021, Matthew has reported no open-market purchases and 25 sales worth $7.0M on SEC Form 4. In the last 12 months: 7 sales ($3.3M).
Their filings also include grants and awards (18 filings), option exercises (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.